Atlas Trials

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

Clinical trial NCT04774419 · RECRUITING

Trial details

NCT number
NCT04774419
Sponsor
Memorial Sloan Kettering Cancer Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2021-04-02
Primary completion
2027-02-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.